Evolución de las infecciones por Pneumocystis Jirovecii en el Hospital de Pediatría Juan P. Garrahan / Evolution of Pneumocystis Jirovecii infections at Hospital de Pediatría Juan P. Garrahan

Pneumocystis jirovecii es un hongo oportunista, causante de neumonía en huéspedes inmunocomprometidos. Es una infección grave con elevada tasa de mortalidad en pacientes oncohematológicos y receptores de trasplante de células progenitoras hematopoyéticas. La administración de corticosteroides es el principal factor de riesgo para adquirir esta infección. Actualmente las infecciones ocurren en aquellos pacientes que no reciben adecuada profilaxis. Las técnicas de diagnóstico molecular son las recomendadas por su elevada sensibilidad, especificidad y rapidez. La frecuencia global de P. jirovecii en pacientes inmunocomprometidos de nuestro hospital, durante el período evaluado fue de 4,8%, con una mortalidad global del 20%. Como factores de mal pronóstico se reportan la presencia de coinfecciones y la necesidad de asistencia respiratoria mecánica. Es importante la sospecha precoz en pacientes de riesgo, confirmada con un diagnóstico preciso mediante métodos moleculares para una intervención adecuada y oportuna (AU)

Pneumocystis jirovecii is an opportunistic fungus, causing pneumonia in immunocompromised hosts. It is a severe infection with a high mortality rate in oncology/hematology patients and hematopoietic stem cell transplant recipients. The administration of corticosteroids is the main risk factor for acquiring this infection. Currently infections occur in patients who do not receive adequate prophylaxis. Molecular diagnostic techniques are recommended because of their high sensitivity, specificity, and speed. In the study period, the overall incidence of P. jirovecii in immunocompromised patients at our hospital was 4.8%, with an overall mortality rate of 20%. Factors of a poor prognosis are the presence of coinfections and the need for mechanical respiratory assistance. Early suspicion in high-risk patients is important to confirm the diagnosis through molecular studies and start adequate and early treatment (AU)

Neumocistosis extrapulmonar: comunicación de un caso / Extrapulmonary pneumocystosis: a case report

We report a case of a middle-age male patient, with newly HIV infection in AIDS stage diagnosis, no comorbitidies, who was hospitalized for subacute malaise, fever, self-limited unproductive cough and no bloody chronic diarrea. The diagnosis of Pneumocystis jiroveci pneumonia was performed by imagenological suspicion and stains of cysts of this pathogen with bronchoalveolar lavage samples. Treatment was initiated with oral cotrimoxazole and starting HAART with good clinical outcome. Concomitantly, an etiologic study was conducted for chronic diarrhea and through histopathological examination of colonic mucosa, numerous extracellular cystic structures Pneumocystis characteristics were observed, performing the diagnosis of extrapulmonary pneumocystosis. Extrapulmonary pneumocystosis is a rare cause of P. jiroveci infection, requires a high index of suspicion and should be approached in HIV patients with severe AIDS which is common in co-infection of various infections and is peremptory to make an etiologic diagnosis and early treatment.

Comunicamos el caso de un varón de edad mediana, con diagnóstico reciente de infección por VIH en etapa SIDA, sin otras co-morbilidades, y cuadro subagudo de compromiso del estado general, fiebre, tos poco productiva autolimitada y diarrea crónica no sanguinolenta. Se realizó el diagnóstico de neumonía por Pneumocystis jiroveci mediante sospecha imagenológica y tinción de quistes de este patógeno en muestras de lavado broncoalveolar. Se inició tratamiento con cotrimoxazol y TARV con buena evolución clínica. En forma concomitante se realizó el estudio etiológico de diarrea crónica y a través del estudio histopatológico de mucosa colónica se observaron numerosas estructuras quísticas extracelulares, características de Pneumocystis por lo que se realizó el diagnóstico de neumocistosis extrapulmonar. La neumocistosis extrapulmonar es una causa infrecuente de infección por P. jiroveci, que requiere un alto índice de sospecha en pacientes con VIH e inmunocompromiso grave, en los cuales es frecuente la co-infección de infecciones oportunistas. Es perentorio realizar un diagnóstico etiológico y tratamiento precoz.

Extra-pulmonary Pneumocystis jiroveci infection: a case report

In physical examination abdominal tenderness, gate disturbance and penile herpetic lesions were detected. Decreased disc height at T11-T12 level was detected in chest X-ray. Abdominal sonography and CT scan revealed hypo dense lesions in Lt left Lobe of liver and multiple hypo dense splenic and pancreatic lesions, ascitis, Lt left sided pleural effusion, thickening of jejuneal mucosa and edema of bowel wall. Vertebral body lesion and paravertebral abscess, bony calvarial involvement and adjacent extra axial brain lesion were observed in imaging were other findings. RNA analysis for HIV was positive. Vertebral lesion biopsy and aspiration of splenic lesion were performed and pathology revealed Pneumocystis jirovecii suggestive of extra pulmonary Pneumocystis carinii infection.

Coinfección pulmonar por Aspergillus fumigatus y Pneumocystis jirovecii en un paciente con VIH-SIDA / Lung coinfection by Aspergillus fumigatus and Pneumocystis jirovecii in an HIV-AIDS patient

Se presenta un caso de coinfección pulmonar por Aspergillus fumigatus y Pneumocystis jirovecii en un paciente con VIH-SIDA. Se diagnosticó con TAC pulmonar, visualización directa con KOH 20 por ciento, tinción de Gomori-Grocott y cultivo del LBA, galactomanano en sangre y de LBA. Se discuten los factores de riesgo, diagnóstico y tratamiento para cada infección.

We report a case of lung coinfection by Aspergillus fumigatus and Pneumocystis jirovecii in a patient with HIV-AIDS. Was diagnosed with lung TAC, direct visualization with KOH 20 percent, Gomori- Grocott staining and culture of BAL, galactomannan in blood and BAL. We discuss risk factors, diagnosis and treatment for each infection.

Pneumocystis jirovecii: cien años de historia / Pneumocystis jirovecii: one hundred years of history

Introducción: Pneumocystis jirovecii es uno de los patógenos oportunistas más importantes que afectan a individuos con síndrome de inmunodeficiencia adquirida y pacientes inmunodeprimidos por otras causas. A pesar de haber sido observado por primera vez hace más de 100 años, se desconocen aún muchos aspectos importantes de su biología y de la morbilidad que produce. Objetivo: en este trabajo se pretende presentar una actualización sobre los principales aspectos de la historia, la epidemiología y la biología de P. jirovecii, así como de la enfermedad que produce. Conclusiones: se han publicado varios artículos de revisión desde su descubrimiento que brindan detalles y elementos novedosos del microorganismo, sin embargo, pocos son los manuscritos encontrados en la literatura de habla hispana que aborden esta problemática.

Introduction: Pneumocystis jirovecii is one of the most important opportunistic pathogens affecting AIDS individuals and immunodepressive patients. In spite of the fact that it was observed one hundred years ago for the first time, many fundamental aspects of its biology and the morbidity it causes are still unknown. Objective: this paper was aimed at presenting updating on the main aspects of the history, the epidemiology and the biology of P. jirovecii and the disease it causes. Conclusions: a number of review articles have been published since the discovery, all of which provide details and novel elements of the microorganism. However, few original papers dealing with this problem have been found in the Spanish literature.

Delayed presentation of severe combined immunodeficiency due to prolonged maternal T cell engraftment

Severe combined immunodeficiency [SCID] is a primary immunodeficiency disorder with heterogenous genetic etiologies. We describe a typical case in a 9-year-old boy that was masked by a clinically functional maternal T cell engraftment leading to late presentation with Pneumocystis jiroveci pneumonia and cytomegalovirus infection, probably following exhaustion of maternally engrafted cells. Based on immunological findings, he had a T- B+SCID phenotype.This report suggests that in rare cases, engrafted maternal T cell might persist for long time leading to partial constitution of immune function and delayed clinical presentation of SCID

Pneumocystis jiroveci in HIV/AIDS patients: detection by FTA filter paper together with PCR in noninvasive induced sputum specimens.

OBJECTIVES: To detect P. jiroveci (previously named P. carinii) by PCR using FTA filter paper to extract the DNA, from noninvasive induced sputum samples of HIV/AIDS patients. MATERIAL AND METHOD: Fifty two HIV/AIDS patients suspected of Pneumocystis jiroveci pneumonia (PJP) in King Chulalongkorn Memorial Hospital were recruited. Both cytological method and PCR with FTA filter paper technique were performed to detect P jiroveci from each specimen. RESULTS: The detectability rate of P. jiroveci infection was 21%. The PCR with FTA filter paper method was 4 folds much more sensitive than Giemsa staining technique. P. jiroveci was detected in 18% of the HIV/AIDS patients in spite of receiving standard PJP prophylaxis. CONCLUSION: Detection of P. jiroveci by using FTA filter paper together with PCR in induced sputum samples could detect more cases of P. jiroveci infection than by using cytological method. DNA extraction using the FTA filter paper was more rapid and convenient than other extraction methods. The causes of failure of PJP prophylaxis should be evaluated.

Pneumocystis carinii in bronchogenic carcinoma compared to other immunocompromised cancer patients using immunofluorescence and immunoperoxidase techniques

Indirect immunofluorescence [IFL] assay was used concomitantly with immunoperoxidase stain for the diagnosis of Pneumocystis carinii in 54 cancer patients with respiratory illness. The specimen analyzed was bronchoalveolar lavage fluid [BALF] in 27 patients complaining mainly of blood-tinged sputum for a period of 3-6 months with cough [group one]. Of these patients, 20 were documented by bronchoscopy and histopathology to be bronchogenic carcinoma [subgroup 1A]. Induced sputum was the test specimen in another 27 cancer patients with cough and expectoration for more than one month during receiving their chemotherapy [group two]. In subgroup 1A, eight BALF specimens showed positivity for P. carinii by both techniques. All positive cases for P. Carinii were belonging to subgroup 1A, i.e. proved bronchogenic carcinoma. The immunoperoxidase technique was slightly more specific and as sensitive as IFL. The IFL gave two false positive results as P. carinii cysts were similar to fungi under the fluorescent microscope. On the other hand, only one patient in group two was positive for P. carinii

Pneumocystis carinii as a causative agent of chest infection in immunocompromised children

Thirty patients were immunocompromised [Group I] and ten were immunocompetent [Group II] as a control group. The diagnosis of pneumocystis carini pneumonia based mainly on detection of P. carini cysts in the respiratory secretions of the radiological findings were nonspecific and unreliable. The cysts were found in 46.7% of the immunocompromised patients by broncho-alveolar lavage [BAL], in 26.7 and 10% by sputum and pharyngeal swabbing, respectively. It is obvious that BAL, although being a difficult and invasive procedure, yet still be needed to either exclude or confirm the disease. However, it is advisable to be carried out in highly susceptible pediatric patients with negative sputum and pharyngeal smears for P. carinii cysts. From the present study, it could be concluded that P. carinii is a common causative agent of pneumonia in immunocompromised children mainly those with acute leukemias

Neumocistosis

La neumocistosis se ha convertido en poco tiempo en una entidad clínica de gran importancia principalmente como consecuencia de la aparición del Síndrome de Inmunodeficiencia adquirida, situación en la cual se comporta como una de las infecciones oportunistas más frecuentes. Debido a que era una entidad poco frecuente, el personal de la salud no está muy familiarizado con la misma y dado que tiene una tendencia hacia el aumento constante, se hace necesario que todo el equipo de salud tenga un nivel de conocimiento adecuado de la enfermedad. Se presenta una revisión actualizada del tema basada en las publicaciones más recientes y puesta en términos muy precisos y prácticos para que pueda ser de utilidad general